Main Article Content

Abstract

BACKGROUND


The health care system around the world is concerned about rational drug use. To achieve this goal, the more vulnerable pediatric population necessitates additional attention. The study's objectives were to determine the most prevalent diseases and medications administered, as per WHO recommendations, by looking at prescription trends and the ailments for which they were prescribed.


Objective


The objective of this study was to find drug use in the outpatient pediatric department of a tertiary care hospital in Jammu and Kashmir.


METHODS


This four-month prospective study was undertaken in the paediatrics department of a tertiary care hospital in Jammu and Kashmir. The Institutional Ethical Committee gave its nod to the investigation, which was then carried out. The parent's or guardian's consent was obtained after discussion and explanation. The patient's and the prescriber's privacy were protected. Every pediatric prescription (from newborn to 12 years old) from the outpatient, inpatient, and critical care units was included in the research.


RESULTS


There were 498 prescriptions in total that were randomly collected and studied. There were a total of 1895 prescriptions, with an average of 4.01 per encounter. Prescriptions from the WHO's essential drug list (666) accounted for 35.14 percent of all prescriptions. There were 397 prescriptions written for antibiotics in total. A total of 79.72 percent of patient encounters involved an antibiotic prescription. The prescribed injections were used in 26.2% of the encounters.


CONCLUSION


With all the indicators, this study gives a positive outlook on drug use, especially for those on the EDL (Essential Drug List). It is possible to improve health care through regular auditing, continuous medical education, and evidence-based medicine (EBM). Drug prescribing patterns in a pediatric outpatient department have been analyzed in this research. To summarize, the role of the clinical pharmacist is critical in pediatrics, both as an integral part of the care team and in clearing up any confusion about the appropriate use of medications. As a pediatric patient, proper drug management is even more critical than for an adult. The prescribing patterns were improved, substantial issues with patients' or caretakers' grasp of consultant instructions were found, and even the financial burden on the patient was lessened with the aid of the WHO core indicators.

Keywords

Pediatrics, Drugs, Rationale, Drug Utilization Evaluation, Prescription Pattern.

Article Details

How to Cite
Mohd Altaf Dar, Mudasir Maqbool, & Irfat Ara. (2023). A Study of Drug Use in the Outpatient Pediatric Department of a Tertiary Care Hospital in Jammu and Kashmir. Journal of Evolution of Medical and Dental Sciences, 12(7), 220–224. https://doi.org/10.14260/jemds.v12i7.443

References

  1. Oamen TE, Osemene KP. Drug utilization evaluation of medications used by hypertensive patients in hospitals in Nigeria. Hospital Topics 2022;100(1):44-53.
  2. Mehta JK, Dhaneria SP, Gaikwad NR, et al. Evaluation of drug utilization pattern of antidiabetic drugs and 10-year cardiovascular risk in new and recently diagnosed type 2 diabetes mellitus patients: a prospective, longitudinal, observational, hospital-based study. International Journal of Diabetes in Developing Countries 2023;43(1):59-65.
  3. Zehravi M, Maqbool R, Maqbool M, et al. To identify patterns of drug usage among patients who seek care in psychiatry outpatient department of a tertiary care hospital in Srinagar, Jammu and Kashmir, India. J Pharm Res Int 2021;33(31A):135-40.
  4. Zehravi M, Maqbool M, Ara I. An overview about safety surveillance of adverse drug reactions and pharmacovigilance in India. Indian Journal of Nutrition and Dietetics 2021;58(3):408.
  5. Maqbool M, Fekadu G, Jiang X, et al. An up to date on clinical prospects and management of osteoarthritis. Ann Med Surg 2021;72:103077.
  6. Maqbool M, Bekele F, Fekadu G. Treatment strategies against triple-negative breast cancer: an updated review. Breast Cancer: Targets and Therapy 2022;14:15-24.
  7. Maqbool M, Dugassa D, Fekadu G. Adverse drug reactions of antiepileptic drugs in the neurology department of a tertiary care hospital, Srinagar, Jammu & Kashmir, India. Arch Neurosci 2021;8(2): e112364.
  8. Maqbool R, Maqbool M, Zehravi M, et al. Menstrual distress in females of reproductive age: a literature review. Int J Adolesc Med Health 2021;34(2):11-7.
  9. Guttula SP, Raju MS, Charan KJ, et al. A study on the drug utilization evaluation of antiepileptics among the pediatric patients at an Indian tertiary care hospital. J Clin Pharmaceut Res 2021;1(3):39-41.
  10. Chandrasekar K, Saju SJ, Zechariah BH, et al. Drug utilization evaluation of aminoglycosides, gentamicin and amikacin: a retrospective study in pediatric patients at secondary care public hospital. Res J Pharm Technol 2021;14(3):1247-50.
  11. Mackie TI, Schaefer AJ, Karpman HE, Lee SM, Bellonci C, Larson J. Systematic review: system-wide interventions to monitor pediatric antipsychotic prescribing and promote best practice. J Am Acad Child Adolesc Psychiatry 2021;60(1):76-104.
  12. Mathew R, Sayyed H, Behera S, et al. Evaluation of antibiotic prescribing pattern in pediatrics in a tertiary care hospital. Avicenna Journal of Medicine 2021;11(1):15-9.
  13. Murali M, Suppes SL, Feldman K, et al. Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children’s hospital. PLoS One 2021;16(1):e0245368.
  14. Benning TJ, Shah ND, Inselman JW, et al. Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of US legislation. Clinical Trials 2021;18(6):732-40.
  15. Morris GA, McNicol M, Boyle B, et al. Increasing biosimilar utilization at a pediatric inflammatory bowel disease center and associated cost savings: show me the money. Inflammatory Bowel Diseases 2022;28(4):531-8.
  16. Zehravi M, Maqbool M, Ara I. Polycystic ovary syndrome and reproductive health of women: a curious association. Int J Adolesc Med Health 2021;33(6):333-7.
  17. Maqbool M, Khan M, Mohammad M, et al. Awareness about reproductive health in adolescents and youth: a review. Journal of Applied Pharmaceutical Sciences and Research 2019;2(3):1-5.
  18. Sokoloff WC, Krief WI, Giusto KA, et al. Pediatric emergency department utilization during the COVID-19 pandemic in New York City. Am J Emerg Med 2021;45:100-4.
  19. Zheng DJ, Umaretiya PJ, Schwartz ER, et al. Disparities in pediatric psychosocial oncology utilization. Pediatric Blood & Cancer 2021;68(11):e29342.
  20. Zehravi M, Maqbool M, Ara I. Depression and anxiety in women with polycystic ovarian syndrome: a literature survey. Int J Adolesc Med Health 2021;33(6):367-73.
  21. Zehravi M, Maqbool M, Ara I. Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review. Open Health 2022;3(1):60-5.
  22. Maqbool M, Ara I, Gani I. The story of polycystic ovarian syndrome: a challenging disorder with numerous consequences for females of reproductive age. International Journal of Current Research in Physiology and Pharmacology 2022;6(3):19-31.
  23. Maqbool M, Nasir N, Mustafa S. Polycystic in ovarian syndrome and its various treatment strategies. Indo American Journal of Pharmaceutical Sciences 2018;5(9):8470-8.
  24. Maqbool M, Bekele F, Fekadu G. Treatment strategies against triple-negative breast cancer: an updated review. Breast Cancer: Targets and Therapy 2022;14:15-24.
  25. Edson-Heredia E, Anderson S, Guo J, et al. Real-world claims analyses of comorbidity burden, treatment pattern, healthcare resource utilization, and costs in pediatric psoriasis. Adv Ther 2021;38(7):3948-61.
  26. Maqbool M, Zehravi M, Maqbool R, et al. Study of adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India. CellMed 2021;11(2):e8.
  27. Lihite RJ, Lahkar M, Das S, et al. A study on adverse drug reactions in a tertiary care hospital of Northeast India. Alexandria Journal of Medicine 2017;53(2):151-6.
  28. Zehravi M, Maqbool M, Ara I. An overview about safety surveillance of adverse drug reactions and pharmacovigilance in India. The Indian Journal of Nutrition and Dietetics 2021;58(3):408-18.
  29. Zehravi M, Maqbool M, Ara I. Polycystic ovary syndrome and infertility: an update. Int J Adolesc Med Health 2021;34(2):1-9.